✦ LIBER ✦

Erratum to: An effective salvage treatment using ifosfamide, etoposide, cytarabine, dexamethasone, and rituximab (R-IVAD) for patients with relapsed or refractory aggressive B-cell lymphoma

✍ Scribed by Katsuhiro Miura; Kazuhiro Takei; Sumiko Kobayashi; Satomi Kiso; Yukio Hirabayashi; Atsuko Hojo; Hitomi Kodaira; Mai Yagi; Daisuke Kurita; Yujin Kobayashi; Toshitake Tanaka; Noriyoshi Iriyama; Yoshihiro Hatta; Yoshimasa Kura; Tetsuo Yamazaki; Umihiko Sawada; Jin Takeuchi

Book ID: 107619338
Publisher: Carden Jennings Publishing
Year: 2011
Tongue: English
Weight: 86 KB
Volume: 94
Category: Article
ISSN: 0925-5710
DOI: 10.1007/s12185-011-0896-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An effective salvage treatment using ifo

An effective salvage treatment using ifosfamide, etoposide, cytarabine, dexamethasone, and rituximab (R-IVAD) for patients with relapsed or refractory aggressive B-cell lymphoma

✍ Katsuhiro Miura; Kazuhiro Takei; Sumiko Kobayashi; Satomi Kiso; Yukio Hirabayash 📂 Article 📅 2011 🏛 Carden Jennings Publishing 🌐 English ⚖ 234 KB

Phase II study of a salvage regimen usin

Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma

✍ Yasuhiro Oki; Michinori Ogura; Harumi Kato; Ako Kikuchi; Hirofumi Taji; Yoshitoy 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB